Phibro Animal Health Co. (NASDAQ:PAHC) Shares Acquired by Virtus Investment Advisers Inc.

Virtus Investment Advisers Inc. increased its holdings in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 103.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 49,504 shares of the company's stock after buying an additional 25,160 shares during the period. Phibro Animal Health comprises about 0.8% of Virtus Investment Advisers Inc.'s holdings, making the stock its 23rd largest position. Virtus Investment Advisers Inc. owned about 0.12% of Phibro Animal Health worth $1,040,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in PAHC. Point72 Asia Singapore Pte. Ltd. purchased a new position in Phibro Animal Health in the 4th quarter valued at about $29,000. Lazard Asset Management LLC lifted its holdings in Phibro Animal Health by 2,739.7% in the 4th quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock valued at $34,000 after purchasing an additional 1,589 shares in the last quarter. Aquatic Capital Management LLC purchased a new position in Phibro Animal Health in the 4th quarter valued at about $69,000. Quantbot Technologies LP lifted its holdings in Phibro Animal Health by 65.1% in the 4th quarter. Quantbot Technologies LP now owns 5,116 shares of the company's stock valued at $107,000 after purchasing an additional 2,018 shares in the last quarter. Finally, Meeder Asset Management Inc. purchased a new position in Phibro Animal Health in the 4th quarter valued at about $113,000. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

Phibro Animal Health Trading Up 1.0%

PAHC traded up $0.22 on Friday, reaching $23.24. 135,439 shares of the company's stock were exchanged, compared to its average volume of 198,566. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. Phibro Animal Health Co. has a twelve month low of $16.16 and a twelve month high of $26.55. The company's 50 day moving average is $20.29 and its 200-day moving average is $21.89. The company has a market cap of $942.01 million, a price-to-earnings ratio of 48.42, a PEG ratio of 0.45 and a beta of 0.62.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.11. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. The company had revenue of $347.80 million during the quarter, compared to the consensus estimate of $352.41 million. Equities analysts predict that Phibro Animal Health Co. will post 1.95 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.07%. The ex-dividend date is Wednesday, June 4th. Phibro Animal Health's payout ratio is currently 61.54%.

Analyst Ratings Changes

A number of research analysts have issued reports on PAHC shares. Morgan Stanley upped their target price on shares of Phibro Animal Health from $20.00 to $21.00 and gave the company an "equal weight" rating in a report on Thursday, May 8th. Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Finally, Barclays increased their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a research report on Monday, February 10th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $20.00.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.